Literature DB >> 15863368

Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum.

Timo J Nevalainen1, Leena I Eerola, Esa Rintala, V Jukka O Laine, Gérard Lambeau, Michael H Gelb.   

Abstract

Time-resolved fluoroimmunoassays (TR-FIA) were developed for all human secreted phospholipases A(2) (PLA(2)), viz. group (G) IB, GIIA, GIID, GIIE, GIIF, GIII, GV, GX and GXIIA PLA(2) and the GXIIB PLA(2)-like protein. Antibodies were raised in rabbits against recombinant human PLA(2) proteins and used in sandwich-type TR-FIAs as both catching and detecting antibodies, the latter after labeling with Europium. The antibodies were non-cross-reactive. The analytical sensitivities were 1 microg/L for the TR-FIA for GIB PLA(2), 1 microg/L (GIIA), 35 microg/L (GIID), 3 microg/L (GIIE), 4 microg/L (GIIF), 14 microg/L (GIII), 11 microg/L (GV), 2 microg/L (GX), 92 microg/L (GXIIA) and 242 microg/L (GXIIB). All secreted PLA(2)s were assayed by these TR-FIAs in serum samples from 34 patients (23 men and 11 women, mean age 53.2 years) treated in an intensive care unit for septic infections, and in control samples from 28 volunteer blood donors (14 men and 14 women, mean age 57.0 years). Five serum samples (3 in the sepsis group and 2 in the blood donor group) gave high TR-FIA signals that were reduced to background (blank) levels by the addition of non-immune rabbit IgG to the sera. This reactivity was assumed to be due to the presence of heterophilic antibodies in these subjects. In all other subjects, including septic patients and healthy blood donors, the TR-FIA signals for GIID, GIIE, GIIF, GIII, GV, GX and GXIIA PLA(2) and the GXIIB PLA(2)-like protein were at background (blank) levels. Four patients in the sepsis group had pancreatic involvement and elevated concentration of GIB PLA(2) in serum (median 19.0 microg/L, range 13.1-33.7 microg/L, n = 4) as compared to the healthy blood donors (median 1.8 microg/L, range 0.8-3.4 microg/L, n = 28, P < 0.0001). The concentration of GIIA PLA(2) in the sera of septic patients (median 315.7 microg/L, range 15.9-979.6 microg/L, n = 34) was highly elevated as compared to that of the blood donors (median 1.8 microg/L, range 0.8-5.8 microg/L, n = 28, P < 0.0001). Our current results confirmed elevated concentrations of GIB and GIIA PLA(2) in the sera of patients suffering from acute pancreatitis or septic infections, respectively, as compared to healthy subjects. However, in the same serum samples, the concentrations of the other secreted PLA(2)s, viz. GIID, GIIE, GIIF, GIII, GV, GX and GXIIA PLA(2) and the GXIIB PLA(2)-like protein were below the respective analytical sensitivities of the TR-FIAs. It is concluded that generalized bacterial infections do not lead to elevated serum levels of GIIE, GIIF, GIII, GV and GX PLA(2)s above the detection limits of the current TR-FIAs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863368     DOI: 10.1016/j.bbalip.2004.12.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  33 in total

1.  Group V secretory phospholipase A2 enhances the progression of angiotensin II-induced abdominal aortic aneurysms but confers protection against angiotensin II-induced cardiac fibrosis in apoE-deficient mice.

Authors:  Boris B Boyanovsky; William Bailey; Lauren Dixon; Preetha Shridas; Nancy R Webb
Journal:  Am J Pathol       Date:  2012-07-17       Impact factor: 4.307

2.  Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice.

Authors:  Jessica Escoffier; Ikram Jemel; Akemi Tanemoto; Yoshitaka Taketomi; Christine Payre; Christelle Coatrieux; Hiroyasu Sato; Kei Yamamoto; Seiko Masuda; Karin Pernet-Gallay; Virginie Pierre; Shuntaro Hara; Makoto Murakami; Michel De Waard; Gérard Lambeau; Christophe Arnoult
Journal:  J Clin Invest       Date:  2010-04-26       Impact factor: 14.808

3.  Blockade of human group X secreted phospholipase A2 (GX-sPLA2)-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective GX-sPLA2 inhibitor.

Authors:  William R Henderson; Rob C Oslund; James G Bollinger; Xin Ye; Ying-Tzang Tien; Jun Xue; Michael H Gelb
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

4.  Absence of inflammatory conditions in human varicose saphenous veins.

Authors:  Ingrid Gomez; Chabha Benyahia; Julien Le Dall; Christine Payré; Liliane Louedec; Guy Leséche; Gérard Lambeau; Dan Longrois; Xavier Norel
Journal:  Inflamm Res       Date:  2012-12-13       Impact factor: 4.575

5.  Antimalarial Activity of Human Group IIA Secreted Phospholipase A2 in Relation to Enzymatic Hydrolysis of Oxidized Lipoproteins.

Authors:  Mélanie Dacheux; Véronique Sinou; Christine Payré; Louise Jeammet; Daniel Parzy; Philippe Grellier; Christiane Deregnaucourt; Gérard Lambeau
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 6.  Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.

Authors:  Nhat D Quach; Robert D Arnold; Brian S Cummings
Journal:  Biochem Pharmacol       Date:  2014-06-04       Impact factor: 5.858

7.  Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A2 (sPLA2).

Authors:  Arnis Kuksis; Waldemar Pruzanski
Journal:  Lipids       Date:  2017-05-20       Impact factor: 1.880

8.  Group IIA-Secreted Phospholipase A2 in Human Serum Kills Commensal but Not Clinical Enterococcus faecium Isolates.

Authors:  Fernanda L Paganelli; Helen L Leavis; Samantha He; Nina M van Sorge; Christine Payré; Gérard Lambeau; Rob J L Willems; Suzan H M Rooijakkers
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

9.  Molecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery disease.

Authors:  Sarah Gora; Claire Perret; Ikram Jemel; Viviane Nicaud; Gérard Lambeau; François Cambien; Ewa Ninio; Stefan Blankenberg; Laurence Tiret; Sonia-Athina Karabina
Journal:  J Mol Med (Berl)       Date:  2009-06-03       Impact factor: 4.599

10.  Effect of prophylactic supplementation with grape polyphenolics on endotoxin-induced serum secretory phospholipase A2 activity in rats.

Authors:  Francis H C Tsao; Bryan J Culver; Joseph F Pierre; Dhanansayan Shanmuganayagam; Calvin C Patten; Keith C Meyer
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.